|
1
|
Guillevin L and Dorner T: Vasculitis:
Mechanisms involved and clinical manifestations. Arthritis Res
Ther. 9 (Suppl 2)(S9)2007.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Langford CA: Vasculitis. J Allergy Clin
Immunol. 125 (Suppl 2):S216–S225. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Trese MGJ, Yonekawa Y, Thomas BJ and
Randhawa S: Vasculitic central retinal vein occlusion: The
presenting sign of seronegative rheumatoid arthritis. Am J
Ophthalmol Case Rep. 2:26–29. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rosenbaum JT, Sibley CH and Lin P: Retinal
vasculitis. Curr Opin Rheumatol. 28:228–235. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Jennette JC: Overview of the 2012 revised
International chapel hill consensus conference nomenclature of
vasculitides. Clin Exp Nephrol. 17:603–606. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Apinyawasisuk S, Rothova A, Kunavisarut P
and Pathanapitoon K: Clinical features and etiology of retinal
vasculitis in Northern Thailand. Indian J Ophthalmol. 61:739–742.
2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fukunaga H, Kaburaki T, Shirahama S,
Tanaka R, Murata H, Sato T, Takeuchi M, Tozawa H, Urade Y, Katsura
M, et al: Analysis of inflammatory mediators in the vitreous humor
of eyes with pan-uveitis according to aetiological classification.
Sci Rep. 10(2783)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kaburaki T, Fukunaga H, Tanaka R, Nakahara
H, Kawashima H, Shirahama S, Izawa H, Komae K, Takamoto M, Soga H
and Aihara M: Retinal vascular inflammatory and occlusive changes
in infectious and non-infectious uveitis. Jpn J Ophthalmol.
64:150–159. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Agarwal A, Karkhur S, Aggarwal K,
Invernizzi A, Singh R, Dogra MR, Gupta V, Gupta A, Do DV and Nguyen
QD: Epidemiology and clinical features of inflammatory retinal
vascular occlusions: Pooled data from two tertiary-referral
institutions. Clin Exp Ophthalmol. 46:62–74. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Grau RG: Drug-induced vasculitis: New
insights and a changing lineup of suspects. Curr Rheumatol Rep.
17(71)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Iwahashi C, Ono H, Haruta M, Minami T,
Mashimo H, Shimojo H and Ohguro N: New onset or exacerbation of
uveitis with infliximab: Paradoxical effects? BMJ Open Ophthalmol.
4(e000250)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Agarwal A, Pilania RK, Anjani G, Choudhary
H, Gupta A and Gupta V: Retinal vasculitis with coats-like response
in a young girl with Parry-Romberg syndrome. J Clin Rheumatol: May
21, 2019 (Epub ahead of print).
|
|
13
|
Mosovich B, Biton A and Avinoach I:
Vasculitis with cutaneous necrosis induced by oral contraceptive.
Harefuah. 120:451–453. 1991.PubMed/NCBI(In Hebrew).
|
|
14
|
Trusau A and Brit ML:
Propylthiouracil-induced ANCA-negative cutaneous small vessel
vasculitis. J Community Hosp Intern Med Perspect. 8:35–37.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wiik A: Drug-induced vasculitis. Curr Opin
Rheumatol. 20:35–39. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kailasam C and Cahill D: Review of the
safety, efficacy and patient acceptability of the
levonorgestrel-releasing intrauterine system. Patient Prefer
Adherence. 2:293–302. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Andersson K, Odlind V and Rybo G:
Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during
five years of use: A randomized comparative trial. Contraception.
49:56–72. 1994.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sturridge F and Guillebaud J: A
risk-benefit assessment of the levonorgestrel-releasing
intrauterine system. Drug Saf. 15:430–440. 1996.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Vrettakos C and Bajaj T: Levonorgestrel.
In: StatPearls [Internet] Treasure Island (FL): StatPearls
Publishing; 2021.
|
|
20
|
Abu El-Asrar AM, Herbort CP and Tabbara
KF: Differential diagnosis of retinal vasculitis. Middle East Afr J
Ophthalmol. 16:202–218. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wildemeersch D, Andrade A, Goldstuck ND,
Hasskamp T and Jackers G: Intrauterine levonorgestrel delivery with
frameless fibrous delivery system: Review of clinical experience.
Int J Womens Health. 9:49–58. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fekete GL and Fekete L: Cutaneous
leukocytoclastic vasculitis associated with erlotinib treatment: A
case report and review of the literature. Exp Ther Med.
17:1128–1131. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mansour D: The benefits and risks of using
a levonorgestrel-releasing intrauterine system for contraception.
Contraception. 85:224–234. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Radic M, Martinović Kaliterna D and Radic
J: Drug-induced vasculitis: A clinical and pathological review.
Neth J Med. 70:12–17. 2012.PubMed/NCBI
|
|
25
|
Papaliodis GN: Ophthalmologic
manifestations of systemic vasculitis. Curr Opin Ophthalmol.
28:613–616. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tugal-Tutkun I: Systemic vasculitis and
the eye. Curr Opin Rheumatol. 29:24–32. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Iliescu DA, Timaru CM, Batras M, De Simone
A and Stefan C: Cogan's syndrome. Rom J Ophthalmol. 59:6–13.
2015.PubMed/NCBI
|
|
28
|
Vollertsen RS: Vasculitis and Cogan's
syndrome. Rheum Dis Clin North Am. 16:433–439. 1990.PubMed/NCBI
|
|
29
|
Behera SK, Das S, Xavier AS, Velupula S
and Sandhiya S: Comparison of different methods for causality
assessment of adverse drug reactions. Int J Clin Pharm. 40:903–910.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Murayama H, Sakuma M, Takahashi Y and
Morimoto T: Improving the assessment of adverse drug reactions
using the Naranjo Algorithm in daily practice: The Japan adverse
drug events study. Pharmacol Res Perspect. 6(e00373)2018.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Naranjo CA, Busto U, Sellers EM, Sandor P,
Ruiz I, Roberts EA, Janecek E, Domecq C and Greenblatt DJ: A method
for estimating the probability of adverse drug reactions. Clin
Pharmacol Ther. 30:239–245. 1981.PubMed/NCBI View Article : Google Scholar
|
